Unknown

Dataset Information

0

Trends in Molecular Markers Associated with Resistance to Sulfadoxine-Pyrimethamine (SP) Among Plasmodium falciparum Isolates on Bioko Island, Equatorial Guinea: 2011-2017.


ABSTRACT: Purpose:Antimalarial drug resistance is one of the major challenges in global efforts to control and eliminate malaria. In 2006, sulfadoxine-pyrimethamine (SP) replaced with artemisinin-based combination therapy (ACT) on Bioko Island, Equatorial Guinea, in response to increasing SP resistance, which is associated with mutations in the dihydrofolate reductase (Pfdhfr) and dihydropteroate synthase (Pfdhps) genes. Patients and Methods:To evaluate the trend of molecular markers associated with SP resistance on Bioko Island from 2011 to 2017, 179 samples collected during active case detection were analysed by PCR and DNA sequencing. Results:Pfdhfr and Pfdhps gene sequences were obtained for 90.5% (162/179) and 77.1% (138/179) of the samples, respectively. For Pfdhfr, 97.5% (158/162), 95.7% (155/162) and 98.1% (159/162) of the samples contained N51I, C59R and S108N mutant alleles, respectively. And Pfdhps S436A, A437G, K540E, A581G, and A613S mutations were observed in 25.4% (35/138), 88.4% (122/138), 5.1% (7/138), 1.4% (2/138), and 7.2% (10/138) of the samples, respectively. Two classes of previously described Pfdhfr-Pfdhps haplotypes associated with SP resistance and their frequencies were identified: partial (IRNI-SGKAA, 59.4%) and full (IRNI-SGEAA, 5.5%) resistance. Although no significant difference was observed in different time periods (p>0.05), our study confirmed a slowly increasing trend of the frequencies of these SP-resistance markers in Bioko parasites over the 7 years investigated. Conclusion:The findings reveal the general existence of SP-resistance markers on Bioko Island even after the replacement of SP as a first-line treatment for uncomplicated malaria. Continuous molecular monitoring and additional control efforts in the region are urgently needed.

SUBMITTER: Lin LY 

PROVIDER: S-EPMC7197940 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Trends in Molecular Markers Associated with Resistance to Sulfadoxine-Pyrimethamine (SP) Among <i>Plasmodium falciparum</i> Isolates on Bioko Island, Equatorial Guinea: 2011-2017.

Lin Li-Yun LY   Li Jian J   Huang Hui-Ying HY   Liang Xue-Yan XY   Jiang Ting-Ting TT   Chen Jiang-Tao JT   Ehapo Carlos Salas CS   Eyi Urbano Monsuy UM   Zheng Yu-Zhong YZ   Zha Guang-Cai GC   Xie Dong-De DD   Wang Yu-Ling YL   Chen Wei-Zhong WZ   Liu Xiang-Zhi XZ   Lin Min M  

Infection and drug resistance 20200428


<h4>Purpose</h4>Antimalarial drug resistance is one of the major challenges in global efforts to control and eliminate malaria. In 2006, sulfadoxine-pyrimethamine (SP) replaced with artemisinin-based combination therapy (ACT) on Bioko Island, Equatorial Guinea, in response to increasing SP resistance, which is associated with mutations in the dihydrofolate reductase (<i>Pfdhfr</i>) and dihydropteroate synthase (<i>Pfdhps</i>) genes.<h4>Patients and methods</h4>To evaluate the trend of molecular  ...[more]

Similar Datasets

| S-EPMC3944859 | biostudies-literature
| S-EPMC7359586 | biostudies-literature
| S-EPMC4957785 | biostudies-literature
| S-EPMC9241599 | biostudies-literature
| S-EPMC5028998 | biostudies-literature
| S-EPMC3384454 | biostudies-literature
| S-EPMC5953477 | biostudies-literature
| S-EPMC8409626 | biostudies-literature
| S-EPMC7390326 | biostudies-literature
| S-EPMC7922716 | biostudies-literature